European Sovereignty Monitor
Sign up free

Industry, investment and R&D

Amsterdam and Zurich's Cradle Bio raises USD 73 million Series B for protein AI

Amsterdam and Zurich based Cradle Bio raised a USD 73 million Series B led by IVP, with Index Ventures and Kindred Capital, for its AI protein engineering platform. Total funding now exceeds USD 100 million.

Verified AI-drafted Cradle Bio blog post, 26 November 2024

What the source does not establish. It does not establish any European government funding or public sector customer for Cradle's platform.

Index score. This item is dated before the index starts on 1 January 2026, so it does not count in the European Sovereignty Index.

How this item was made. Drafted by an AI system (Claude (Anthropic)) from the source cited above and published under the editor’s responsibility without a person reading it first. How the record is made

What the tags mean: VerifiedReportedAI-draftedAI-drafted, editor-readHuman-writtenWhat the tags mean

Previously in Industry, investment and R&D

ReportedAI-drafted EU's EIC backs Paris satellite-to-phone start-up Univity with up to EUR 12.5 million VerifiedAI-drafted Wallenberg Investments takes minority stake in Swedish simulation firm Algoryx ReportedAI-drafted Dutch startup Elysian Aircraft raises over EUR 12 million for dual-use aircraft tech

All Industry, investment and R&D news →